Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2003
03/20/2003WO2003022360A2 Thermotherapy via targeted delivery of nanoscale magnetic particles
03/20/2003WO2003022324A1 Medical devices containing rapamycin analogs
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022297A1 Biodegradable implant comprising a polylactide polymer and a lh-rh analogue
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022287A1 USE OF 3β-HYDROXY-5-SPIROSTENE AS DRUGS FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES OR CONDITIONS FOR INHIBITION OF TUMORS AND DECREASING OF BLOOD LIPIDS
03/20/2003WO2003022282A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022274A2 2-aroylimidazole compounds for treating cancer
03/20/2003WO2003022273A1 Methods of treating cytokine mediated diseases
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003022266A1 Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
03/20/2003WO2003022264A1 Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022260A1 Use of methotrexate and l-arginine for the preparation of a medicament for treatment of uterine myoma
03/20/2003WO2003022259A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003WO2003022258A1 Aryloxypropylamines as chemosensitizing agent in the treatment of cancer
03/20/2003WO2003022253A1 Dosage forms having prolonged active ingredient release
03/20/2003WO2003022252A2 Combinatorial type (several vehicles within a housing) controlled release drug delivery device
03/20/2003WO2003022248A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022247A1 Injectable composition of paclitaxel
03/20/2003WO2003022244A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent
03/20/2003WO2003022225A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003WO2003022219A2 Biarylamino purine antiproliferative agents
03/20/2003WO2003022216A2 Biaryl substituted purine derivatives as potent antiproliferative agents
03/20/2003WO2003022202A2 Compositions and methods for treatment of cancer
03/20/2003WO2003006055A8 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
03/20/2003WO2003004466A3 Dye-sulfenates for dual phototherapy
03/20/2003WO2003004046A3 Use of xaa-pro peptidases for the treatment of substance p-related disorders
03/20/2003WO2003000848A3 Liver engrafting cells, assays, and uses thereof
03/20/2003WO2003000011A3 Novel pyridopyrimidines and uses thereof
03/20/2003WO2002102344A3 No-synthase inhibitor and use thereof
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
03/20/2003WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/20/2003WO2002087509A3 Colloidal metal compositions and methods
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002078614A3 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
03/20/2003WO2002077184A3 Oligonucleotide conjugates
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003WO2002066040A8 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
03/20/2003WO2002060373A3 Indole derivatives and their uses as heparanase inhibitors
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002047697A8 Fractions of snake blood, their preparation and use as therapeutic agents
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002040529A3 Diastereomeric peptides and pharmaceutical compositions comprising them
03/20/2003WO2002039996A3 Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists
03/20/2003WO2002030886A3 Heterocyclic angiogenesis inhibitors
03/20/2003WO2002028408A3 Compositions and methods for the transport of biologically active agents across cellular barriers
03/20/2003WO2002024897A9 Conditionally replicating viral vectors and their use
03/20/2003WO2002021138A3 The m30 gene family and the utilization thereof
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002012245B1 Azabicyclic derivatives and their therapeutic use
03/20/2003WO2002012188B1 Indole compounds useful for the treatment of cancer
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2001090153A3 Reagents for cell selection and methods of use
03/20/2003WO2001088546A3 Treatments and markers for cancers of the central nervous system
03/20/2003WO2001085219A3 Identification, diagnosis, and treatment of breast cancer
03/20/2003WO2001073104A9 Beta-glucans from filamentous fungi
03/20/2003WO2001072341A3 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
03/20/2003US20030056241 Chicken leukemia inhibitory factor (LIF) and gene thereof
03/20/2003US20030055307 Devices for detection and therapy of atheromatous plaque
03/20/2003US20030055272 Antileukemia and antitumor agents
03/20/2003US20030055260 Il-8 receptor antagonists
03/20/2003US20030055258 New crystal modification of torasemide
03/20/2003US20030055248 Il-8 receptor antagonists
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055227 Process for obtaining lignan
03/20/2003US20030055226 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
03/20/2003US20030055217 Peptides derived from STEAP1
03/20/2003US20030055111 For use in preparation of medicaments for the treatment of tumors and rheumatoid arthritis
03/20/2003US20030055105 Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids
03/20/2003US20030055097 Indazolyl-substituted pyrroline compounds as kinase inhibitors
03/20/2003US20030055072 Methods of inhibiting Pin1-associated states using a fredericamycin a compound
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055065 Administering tricyclic amide and urea compounds for inhibiting the abnormal growth of cells
03/20/2003US20030055061 Therapy of disease or condition which is caused by a disorder of the serotonin system by administering 2,7-substituted octahydro-1H-pyrido(1,2-a)pyrazine derivatives, and their acid addition salts
03/20/2003US20030055056 For use as antitumor and immune suppressive agents, as inhibitors of proliferative cell growth and as prophylactic agents to inhibit and prevent cancer and non-malignant cell growth
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055049 For therapy of abnormal cell growth, such as cancer, in mammals
03/20/2003US20030055048 Compositions and methods for treating or preventing convulsions or seizures
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055041 Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors
03/20/2003US20030055032 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
03/20/2003US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human
03/20/2003US20030055015 Therapy and prophylaxis of diseases
03/20/2003US20030055014 Administering at least one antiangiogenic nucleic acid molecule in an amount effective to inhibit angiogenesis
03/20/2003US20030055006 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
03/20/2003US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy
03/20/2003US20030055002 For cancer therapy
03/20/2003US20030054996 Contacting complex comprising a GRP94 protein with a binding agent that is immobilized to a solid phase support, to immobilize the complex to solid phase support; collecting the remaining sample; eluting the complex from solid phase support
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054490 Isolated human phosphatase proteins, nucleic acid molecules encoding phosphatase proteins and uses thereof
1 ... 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 ... 2211